PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy ...Middle East

- News
PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy
According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).

Hence then, the article about pet mri ct metrics assess pathologic response of pancreas cancer to neoadjuvant therapy was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy )

Apple Storegoogle play

Last updated :

Also on site :